HealthEquity (HQY) is an Incredible Growth Stock: 3 Reasons Why

HealthEquity (HQY) is identified as a compelling growth stock due to its favorable Zacks Growth Style Score of B and a Zacks Rank #2 (Buy). The company's projected EPS growth of 15.8% significantly exceeds the industry average of 7.7%, and its year-over-year cash flow growth stands at 25.9% compared to the industry average of -1.5%. Furthermore, current-year earnings estimates for HealthEquity have increased by 6.5% over the past month, reinforcing its potential for near-term stock price appreciation.

Analysis

HealthEquity (HQY) exhibits strong indicators of a growth stock, supported by a Zacks Growth Style Score of B and a Zacks Rank #2 (Buy). The company's projected EPS growth for the current year is 15.8%, significantly outperforming the industry average of 7.7%. This earnings outlook is further bolstered by robust cash flow metrics; HealthEquity's year-over-year cash flow growth is reported at 25.9%, a stark contrast to the industry average decline of 1.5%. Such strong cash flow growth is particularly beneficial for growth-oriented companies, enabling expansion without dependence on costly external financing. Historically, HealthEquity has maintained an annualized cash flow growth rate of 19.3% over the past 3-5 years, compared to the industry's 8%. Reinforcing this positive outlook, the Zacks Consensus Estimate for HealthEquity's current-year earnings has surged by 6.5% over the past month, a trend empirically linked to near-term stock price movements. These combined factors suggest a company with strong financial momentum and promising growth prospects.

Key Decisions for Investors

• Investors with a growth-focused strategy should consider HealthEquity due to its superior projected EPS and cash flow growth relative to its industry, coupled with positive earnings estimate revisions.
• It is advisable to monitor the company's continued performance against these growth metrics and any changes in analyst sentiment, as these are pivotal to its valuation and stock performance.
• Given that growth stocks inherently carry above-average risk and volatility, investors should assess their risk tolerance and potentially size positions accordingly, despite the currently favorable indicators for HealthEquity.